Contact
searchSearch
HMP Global

Psoriasis Excellence Forum

Featured

brad glick
Videos
Oral Therapies in Psoriasis
04/01/2026
Riya Gandhi, MA
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses...
04/01/2026
The Dermatologist
wells
Clinical Insights
Addressing Unmet Needs in Psoriatic Arthritis: Diagnosis, Pathogenesis, and Newer/Emerging Oral Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a...
03/02/2026
The Dermatologist
Blauvelt
Clinical Insights
Transforming Psoriasis Care: Oral IL-23 Therapy and the Next Frontier in Patient-Centered Treatment
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that...
03/02/2026
The Dermatologist
Krueger
Clinical Insights
Advancing Oral Therapies in Psoriasis: Targeted Innovation for Improved Disease Control and Patient Adherence
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr...
03/02/2026
The Dermatologist
Dr Blauvelt
Conference Coverage
Plaque Psoriasis Treatment Therapeutics: Oral IL-23 Inhibitors
02/22/2026
Riya Gandhi, MA
A clinical update on oral IL-23 therapy for plaque psoriasis, highlighting icotrokinra phase 3 data, superiority vs deucravacitinib, TYK2 inhibitors (zasocitinib, envudeucitinib), and patient-centered treatment strategies.
A clinical update on oral IL-23 therapy for plaque psoriasis, highlighting icotrokinra phase 3 data, superiority vs deucravacitinib, TYK2 inhibitors (zasocitinib, envudeucitinib), and patient-centered treatment strategies.
A clinical update on oral IL-23...
02/22/2026
The Dermatologist
Dr Wells
Conference Coverage
Oral Therapy in Psoriatic Arthritis: JAK, TYK2, and the End of Methotrexate Monotherapy?
02/22/2026
Riya Gandhi, MA
A clinical update on psoriatic arthritis diagnosis and oral therapy, highlighting JAK/STAT pathogenesis, apremilast (PALACE), deucravacitinib (POETYK PsA-1/2), methotrexate safety concerns, and individualized treatment strategies.
A clinical update on psoriatic arthritis diagnosis and oral therapy, highlighting JAK/STAT pathogenesis, apremilast (PALACE), deucravacitinib (POETYK PsA-1/2), methotrexate safety concerns, and individualized treatment strategies.
A clinical update on psoriatic...
02/22/2026
The Dermatologist
Dr Weber
Conference Coverage
From Psoriasis to Plaque: Why Cardiovascular Risk Belongs in Every Dermatology Visit
02/20/2026
Riya Gandhi, MA
A cardio-dermatology update on psoriasis, psoriatic arthritis, coronary computed tomography angiography, coronary artery calcium-AI imaging, and cardiovascular risk prevention in immune-mediated inflammatory disease.
A cardio-dermatology update on psoriasis, psoriatic arthritis, coronary computed tomography angiography, coronary artery calcium-AI imaging, and cardiovascular risk prevention in immune-mediated inflammatory disease.
A cardio-dermatology update on...
02/20/2026
The Dermatologist
Dr Weber
Conference Coverage
GLP-1 Agonists in Psoriatic Disease: Beyond Weight Loss to Cardiovascular and Inflammatory Benefit
02/20/2026
Riya Gandhi, MA
A clinical update on GLP-1 receptor agonists in psoriasis and psoriatic arthritis, highlighting cardiovascular outcomes, SELECT trial data, obesity-driven inflammation, and combination therapy results.
A clinical update on GLP-1 receptor agonists in psoriasis and psoriatic arthritis, highlighting cardiovascular outcomes, SELECT trial data, obesity-driven inflammation, and combination therapy results.
A clinical update on GLP-1...
02/20/2026
The Dermatologist
Andrew Blauvelt
Videos
Oral IL-23 Therapies in Psoriasis: Addressing Undertreatment, Adherence, and Patient Preference
02/17/2026
Riya Gandhi, MA
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how...
02/17/2026
The Dermatologist
psoriasis
Quiz
Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
The Central Message of World Psoriasis Day 2025
11/06/2025
Jessica Garlewicz
Which of the following best reflects a central message of World Psoriasis Day 2025 and its emphasis on comorbidities in psoriatic disease?
Which of the following best reflects a central message of World Psoriasis Day 2025 and its emphasis on comorbidities in psoriatic disease?
Which of the following best...
11/06/2025
The Dermatologist

From the Journal

Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist
NPF Endorsed Features
Psoriatic Disease and the Domino Effect of Comorbidities
10/06/2025
Lisa Kuhns, PhD, MD
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown...
10/06/2025
The Dermatologist
NPF Endorsed Features
Salon to Skin: How Dermatologists and Hair Stylists Can Work Together
08/02/2025
Samantha Schlosser
With a passion for hair loss and ethnic skin, Dr Chesahna Kindred is bridging the gap between beauty and medicine through the S.T.R.A.N.D. Network.
With a passion for hair loss and ethnic skin, Dr Chesahna Kindred is bridging the gap between beauty and medicine through the S.T.R.A.N.D. Network.
With a passion for hair loss and...
08/02/2025
The Dermatologist
NPF Endorsed Features
Highlights From the 2024 Psoriasis Health Indicator Report
02/03/2025
Lisa Kuhns, PhD, MD
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis...
02/03/2025
The Dermatologist
NPF Endorsed Features
Reexamining Remission in Psoriasis
10/07/2024
Jess Smith, BS
Results from a recent study can inform future efforts to develop or modify definitions of remission for the psoriatic disease community.
Results from a recent study can inform future efforts to develop or modify definitions of remission for the psoriatic disease community.
Results from a recent study can...
10/07/2024
The Dermatologist
NPF Endorsed Features
Phone-a-Friend: Exploring the Collaborative Care Model in Psoriasis
08/06/2024
Samantha Koons
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of...
08/06/2024
The Dermatologist
NPF Endorsed Features
What’s New in Psoriasis Research
05/03/2024
Jessica Garlewicz; Riya Gandhi, MA
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this...
05/03/2024
The Dermatologist
NPF Endorsed Features
Understanding Generalized Pustular Psoriasis
12/05/2023
Jessica Garlewicz
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history...
12/05/2023
The Dermatologist
Cover Story
Cardiovascular Risk and Psoriasis
10/20/2023
Joel M. Gelfand, MD, MSCE
Heart disease is the #1 killer in the United States. By screening our patients with psoriasis who are predisposed to heart disease for cardiovascular risk factors, we can help them live longer, healthier lives.
Heart disease is the #1 killer in the United States. By screening our patients with psoriasis who are predisposed to heart disease for cardiovascular risk factors, we can help them live longer, healthier lives.
Heart disease is the #1 killer...
10/20/2023
The Dermatologist
NPF Endorsed Features
Psoriasis Clinical Trial Travel Challenges
10/17/2023
Jessica Garlewicz
Being mindful of transportation as a potential barrier to obtaining care can improve patients’ quality of life.
Being mindful of transportation as a potential barrier to obtaining care can improve patients’ quality of life.
Being mindful of transportation...
10/17/2023
The Dermatologist
Case Report
Phototoxic Drug Eruption to Novel Anticancer Agent Pidnarulex
10/05/2026
Shannon C. Lyden, BS; Priya Gupta, BA; Ernest Moore, BA; Nabiha Islam, MD; Brittany Dulmage, MD; Abraham M. Korman, MD
Prompt dermatologic recognition of this reaction pattern, combined with dose adjustment rather than discontinuation, may allow patients to safely continue a promising anticancer therapy.
Prompt dermatologic recognition of this reaction pattern, combined with dose adjustment rather than discontinuation, may allow patients to safely continue a promising anticancer therapy.
Prompt dermatologic recognition...
10/05/2026
The Dermatologist
Derm Dx
What Caused This Hyperpigmentation?
10/02/2026
Lanah Almatroud, BA; Rania Djemil, BS; Amor Khachemoune, MD, FAAD, FACMS
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran,...
10/02/2026
The Dermatologist
Cover Story
The Industry Dermatologist: Building a Career at the Intersection of Science, Innovation, and Patient Care
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
Cover Story
Dermatology in the Digital Age: How Technology Is Transforming Clinical Practice
09/03/2026
Daniel M. Siegel, MD, MS, FAAD, FACMS; Riya Gandhi, MA
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness...
09/03/2026
The Dermatologist
Feature Story
The Eye-Skin Connection: Ocular Red Flags Every Dermatologist Should Know
09/03/2026
Jennifer Cao, MD; Riya Gandhi, MA
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular...
09/03/2026
The Dermatologist
Derm Dx
What Is the Cause of This Color Change on the Neck?
09/03/2026
Sümeyye Aktaş, MD; Mehmet Ali Demirci, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented...
09/03/2026
The Dermatologist
Case Report
Reed Nevus
09/03/2026
Lanah Almatroud, BA; Rania Djemil, BS; Şükrü Yildirim, MD, PhD; Elif Müyesseroğlu; Amor Khachemoune, MD, FAAD, FACMS
In this benign, genetically defined spitzoid lesion, characteristic pigmentation and spindle cell morphology reflect underlying kinase-driven pathways rather than malignant potential.
In this benign, genetically defined spitzoid lesion, characteristic pigmentation and spindle cell morphology reflect underlying kinase-driven pathways rather than malignant potential.
In this benign, genetically...
09/03/2026
The Dermatologist
Feature Story
Special Delivery of Topical Interest: Understanding Vehicle Formulation for Nonsteroidal Prescription Eczema Creams
08/04/2026
Julia Ross, MD; Noah A. Levit, MD, PhD, FAAD
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the...
08/04/2026
The Dermatologist
Derm Dx
What Are These Pigmented, Pedunculated Lesions?
08/04/2026
Tanya Henry, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American...
08/04/2026
The Dermatologist
Case Report
Recurrent Inflammatory Plaques on Upper Extremities in a Patient With Breast Cancer Surgery History
08/04/2026
Shannon C. Lyden, BS; Abraham M. Korman, MD
The presented case aims to improve the recognition of intravascular histiocytosis, a rare reactive skin condition.
The presented case aims to improve the recognition of intravascular histiocytosis, a rare reactive skin condition.
The presented case aims to...
08/04/2026
The Dermatologist

Expert Insights

brad glick
Videos
Oral Therapies in Psoriasis
04/01/2026
Riya Gandhi, MA
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses...
04/01/2026
The Dermatologist
Andrew Blauvelt
Videos
Oral IL-23 Therapies in Psoriasis: Addressing Undertreatment, Adherence, and Patient Preference
02/17/2026
Riya Gandhi, MA
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how...
02/17/2026
The Dermatologist
Saakshi-Khattri
Videos
Recap: Dual Diagnosing and Managing Psoriasis and Psoriatic Arthritis
04/16/2024
Saakshi Khattri, MD, FACR, FAAD
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the...
04/16/2024
The Dermatologist
Steven Feldman
Videos
Optimizing Psoriasis Care: Phototherapy, Adherence, & Insights
09/05/2023
Steven R. Feldman, MD, PhD
In this interview with The Dermatologist, Dr Steven Feldman discusses his upcoming session, “Better Care for Psoriasis Patients,” to be presented at Dermatology Week Fall 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his upcoming session, “Better Care for Psoriasis Patients,” to be presented at Dermatology Week Fall 2023.
In this interview with The...
09/05/2023
The Dermatologist
Ron Vender
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
07/13/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
07/13/2023
The Dermatologist
Eric Beltrami, MD
Videos
Travel Distance and Time to Psoriasis Clinical Trial Sites
06/23/2023
Eric Beltrami, MD; Hao Feng, MD, MHS
Drs Eric Beltrami and Hao Feng discuss the travel and time burdens surrounding psoriasis clinical sites following their study.
Drs Eric Beltrami and Hao Feng discuss the travel and time burdens surrounding psoriasis clinical sites following their study.
Drs Eric Beltrami and Hao Feng...
06/23/2023
The Dermatologist
Andrea D. Maderal, MD
Videos
Insurance Delays in the Approval of Biologic Medications for Patients With Psoriasis
02/27/2023
Andrea D. Maderal, MD; Thomas Vazquez, MD
In this feature video, Drs Maderal and Vazquez discuss their recent review on how insurance approval and the need for prior authorization can be barriers to care for patients with psoriatic disease.
In this feature video, Drs Maderal and Vazquez discuss their recent review on how insurance approval and the need for prior authorization can be barriers to care for patients with psoriatic disease.
In this feature video, Drs...
02/27/2023
The Dermatologist
psoriasis
Videos
Does Body Region Affected by Psoriasis Influence Quality of Life?
02/13/2023
Riya Gandhi, MA
In this interview, Ron Vender, MD, FRCPC, discusses why patients with psoriasis have a decreased quality of life no matter where they have skin involvement.
In this interview, Ron Vender, MD, FRCPC, discusses why patients with psoriasis have a decreased quality of life no matter where they have skin involvement.
In this interview, Ron Vender,...
02/13/2023
The Dermatologist
Emily Renee Strouphauer
Videos
Anxiety and Depression Among Pediatric Patients with Psoriasis
12/08/2022
Emily Renee Strouphauer
In this video, Emily Renee Strouphauer discusses her recent study on the impact of psoriasis in pediatric patients.
In this video, Emily Renee Strouphauer discusses her recent study on the impact of psoriasis in pediatric patients.
In this video, Emily Renee...
12/08/2022
The Dermatologist
Jashin J. Wu, MD, FAAD
Videos
Dr Jashin Wu on Biologics in Psoriasis
04/22/2022
Jashin J. Wu, MD, FAAD
Dr Jashin Wu discussed biologics and emerging therapeutic options for psoriatic disease prior to his session at AAD annual meeting.
Dr Jashin Wu discussed biologics and emerging therapeutic options for psoriatic disease prior to his session at AAD annual meeting.
Dr Jashin Wu discussed biologics...
04/22/2022
The Dermatologist
Dr Lisa Swanson
Videos
Pediatric Atopic Dermatitis: Diagnosis, Treatment Selection, and Long-Term Health Considerations
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
KOL Roundtable
Videos
Type 2 Inflammation as an Underlying Disease Driver
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist
Brian Kim
Videos
From Cytokines to Clinic: Translating Type 2 Biology Into Prurigo Nodularis Treatment
11/01/2026
Brian Kim, MD, MTR, FAAD; Riya Gandhi, MA
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4...
11/01/2026
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz; Elizabeth Swanson, MD
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes

psoriasis
Quiz
Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
The Central Message of World Psoriasis Day 2025
11/06/2025
Jessica Garlewicz
Which of the following best reflects a central message of World Psoriasis Day 2025 and its emphasis on comorbidities in psoriatic disease?
Which of the following best reflects a central message of World Psoriasis Day 2025 and its emphasis on comorbidities in psoriatic disease?
Which of the following best...
11/06/2025
The Dermatologist
psoriasis
Quiz
Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
psoriasis rash
Quiz
Mental Health and Psoriasis
12/20/2022
Jessica Garlewicz
True or false: Adults with psoriasis are 2 to 3 times more likely to develop depression.
True or false: Adults with psoriasis are 2 to 3 times more likely to develop depression.
True or false: Adults with...
12/20/2022
The Dermatologist
doctor with couple
Quiz
Feelings Among Family Members of Patients with AD and PsO
12/13/2022
Jessica Garlewicz
Which option describes commonly expressed feelings among family members of patients with atopic dermatitis and psoriasis?
Which option describes commonly expressed feelings among family members of patients with atopic dermatitis and psoriasis?
Which option describes commonly...
12/13/2022
The Dermatologist
psoriasis generalized pustular
Quiz
Optimizing Patient Care
11/29/2022
Jessica Garlewicz
What score should patients with psoriasis have on the Psoriasis Epidemiology Screening Test to qualify for further investigation?
What score should patients with psoriasis have on the Psoriasis Epidemiology Screening Test to qualify for further investigation?
What score should patients with...
11/29/2022
The Dermatologist
Physician with child
Quiz
Pediatric Patients With Atopic Dermatitis Receiving Dupilumab
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
Therapeutic Response Heterogeneity and Precision Medicine in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
Neuroimmune Interactions and Disease Persistence in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
Understanding Type 2 Inflammation Across Inflammatory Skin Diseases
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use